Study Details

Back to Search Results

A Study to Assess Pharmacokinetic, Pharmacodynamic, Safety and Tolerability of ASKP1240 in de novo Kidney Transplantation

This trial is complete
The study has ended normally, and participants are no longer being examined or treated (that is, the last participant's last visit has occurred).

Clinicaltrials.gov ID

The unique identification code given to each clinical study upon registration at ClinicalTrials.gov.
NCT01279538

Astellas Study ID

The unique identification code given by the study sponsor.

7163-CL-0103

EudraCT ID

The unique identification code given to each clinical study upon registration at EudraCT (European Union Drug Regulating Authorities Clinical Trials Database).

N/A

Follow Trial

Condition

Kidney Transplants

Phase

These clinical trials are usually the first time an experimental treatment is studied in a small group of people.

Phase 1

Age

18 years - 65 years

Sex

Female & Male

Product

N/A

Type

A type of clinical study in which participants are assigned to groups that receive one or more intervention/treatment (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.

Interventional

Trial Dates

Nov 2010 - Jan 2012

Masking

Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Enrollment number

50

A Phase 1b, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Single-Dose, Pharmacokinetic, Pharmacodynamic, Safety and Tolerability Study of ASKP1240 in de novo Kidney Transplantation

Study summary

Get More Information

Would you like more information about clinical trial sites that are recruiting participants for A Study to Assess Pharmacokinetic, Pharmacodynamic, Safety and Tolerability of ASKP1240 in de novo Kidney Transplantation? Contact us by filling our your information to the right and we’ll respond to you.

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

Locations

The Methodist Hospital

Houston, United States, 77030

California Institute of Renal Research

San Diego, United States, 92123

University of Utah Hospital

Salt Lake City, United States, 84132

University of Colorado Denver

Aurora, United States, 80045

University of North Carolina at Chapel Hill

Chapel Hill, United States, 27599

University of Wisconsin

Madison, United States, 53705

Emory University

Atlanta, United States, 30322

University of Illinois Medical Center

Chicago, United States, 60612

University of Michigan

Ann Arbor, United States, 48109

Duke University Medical Center

Durham, United States, 27710

California Pacific Medical Center

San Francisco, United States, 94115

UCSF Medical Center

San Francisco, United States, 94143

Christ Hospital

Cincinnati, United States, 45219

St. Barnabas Medical Center

Livingston, United States, 07039

Methodist University Hospital

Memphis, United States, 38104

Beth Israel Deaconess Medical Center, The Transplant Institute

Boston, United States, 02215

Stanford University Medical Center

Palo Alto, United States, 94304

Baylor University Medical Center

Dallas, United States, 75246

Central Pennsylvania Transplant Associates

Harrisburg, United States, 17104

Westchester Medical Center

Valhalla, United States, 10595

Loyola University Medical Center

Maywood, United States, 60153

University of Cincinnati - University Internal Medicine Associates

Cincinnati, United States, 45219

The purpose of this website is to offer education and information to patients and their families and friends, the public, and healthcare professionals about the clinical trial process. In addition, the website will provide specific information about Astellas clinical trials. Please read the complete Astellas Transparency Policy to learn about the clinical trial information available on this website

© ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.

POWERED BY:

Pharma Intelligence logo